September 2011/NutraSolutions -- Lonza announced its International Patent Application was published by the World Intellectual Property Organization (WIPO) for Larch Arabinogalactan (LAG), the key component in the immune ingredient, ResistAid™. The application contains patent claims relating to LAG’s positive effect on the adaptive arm of the immune system prior to, during and after exposure to foreign antigens. Furthermore, the application claims potential use in a vaccination kit comprising of a composition with Arabinogalactan and a vaccine. While previous research demonstrated the ability of ResistAid to strengthen and support the innate arm of the immune system, the newest research results broaden the understanding of ResistAid and its ability to enhance the adaptive arm of the immune system. Lonza, www.lonza.com NS